© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
May
Cancer Care Value-Learning From Others
May 24, 2012
Article
Evidence-Based Oncology
Getting Smarter in How We Score and Promote Value
Value-Based Reimbursement in Oncology
May 24, 2012
Article
Evidence-Based Oncology
Getting On Pathway?
Testing for ALK-Positive NSCLC
May 24, 2012
Article
Evidence-Based Oncology
Signaling the Future of Personalized Medicine
Long-Term Breast Cancer Patient Follow-Up Care
May 24, 2012
Article
Evidence-Based Oncology
Money Well Spent?
BRCA1/2 Genetic Testing Found Cost-Effective in Current Era
May 24, 2012
Article
Evidence-Based Oncology
SABCS Conference Coverage
Trends in the 2012 Eisai Oncology Digest: Patient Demographics and Cancer Treatment Goals
May 24, 2012
Article
Evidence-Based Oncology
This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.
Literature Review
May 24, 2012
Article
Evidence-Based Oncology
Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy
On the Horizon for Multiple Myeloma
May 24, 2012
Article
Evidence-Based Oncology
Availability of Newer Agents May Lower Healthcare Costs
Oncology Hit Hard by SGR Debacle
May 24, 2012
Article
Evidence-Based Oncology
Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology
Forging a Pathway to Quality Cancer Care
May 23, 2012
Article
Evidence-Based Oncology
UPMC Oncologists: Pioneers in the Clinical Pathways Movement